Livius V. d’Uscio - Concepedia

Author

Livius V. d’Uscio

Also Known As

L V d'Uscio, L d'Uscio, L. V. d'Uscio, LIVIUS V. D'USCIO, Livius V d'Uscio, Livius V d’Uscio, Livius V. D'USCIO, Livius V. d'Uscio, Livius V. d'uscio, Livius V. dʼUscio

109

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic University Hospital of Zurich University of Zurich University Hospital of Bern University of Bern

About

Livius V. d’Uscio is an author at Mayo Clinic specializing in medicine, vascular biology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	1.7K
2	Biochemistry	7	7	825
3	Health Sciences	6	6	450
4	Natural Sciences	2	2	39
5	Social Sciences	2	2	97

Livius V. d’Uscio

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Endothelin ET <sub>A</sub> receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice Matthias Barton, Christian C. Haudenschild, Livius V. d’Uscio, Proceedings of the National Academy of Sciences	1998	356
Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. Francesco Cosentino, Stephen R. Patton, Livius V. d’Uscio, Journal of Clinical Investigation HypertensionNitric Oxide ReleaseNitric OxideLipid PeroxidationIsometric Tension	1998	348
Angiotensin II Increases Tissue Endothelin and Induces Vascular Hypertrophy Pierre Moreau, Livius V. d’Uscio, Sidney Shaw, Circulation	1997	326
Long-Term Vitamin C Treatment Increases Vascular Tetrahydrobiopterin Levels and Nitric Oxide Synthase Activity Livius V. d’Uscio, Sheldon Milstien, Darcy M. Richardson, Circulation Research Vascular DiseaseLipid PeroxidationOxidative StressInflammationMetabolic Syndrome	2003	295
Angiotensin II Increases Vascular and Renal Endothelin-1 and Functional Endothelin Converting Enzyme Activityin Vivo:Role of ETAReceptors for Endothelin Regulation Matthias Barton, Sidney Shaw, Livius V. d’Uscio, Biochemical and Biophysical Research Communications MedicineVascular PharmacologyPhysiologyEndothelial DysfunctionRenal Inflammation	1997	195
ET <sub>A</sub> Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension Matthias Barton, Livius V. d’Uscio, Sidney Shaw, Hypertension	1998	176
Mechanism of Endothelial Dysfunction in Apolipoprotein E–Deficient Mice Livius V. d’Uscio, Timothy A. Baker, Carlos B. Mantilla, Arteriosclerosis Thrombosis and Vascular Biology	2001	159
Effects of Chronic ET<sub>A</sub>-Receptor Blockade in Angiotensin II-Induced Hypertension Livius V. d’Uscio, Pierre Moreau, Sidney Shaw, Hypertension	1997	147
Structure and Function of Small Arteries in Salt-Induced Hypertension Livius V. d’Uscio, Matthias Barton, Sidney Shaw, Hypertension	1997	128
Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities Thomas R. Coleman, Christof Westenfelder, Florian Tögel, Proceedings of the National Academy of Sciences	2006	126

Page 1